Jan Unkelbach1, Pablo Botas2, Drosoula Giantsoudi3, Bram L Gorissen3, Harald Paganetti3. 1. Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: junkelbach@mgh.harvard.edu. 2. Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts; Faculty of Physics, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany. 3. Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts.
Abstract
PURPOSE: We describe a treatment plan optimization method for intensity modulated proton therapy (IMPT) that avoids high values of linear energy transfer (LET) in critical structures located within or near the target volume while limiting degradation of the best possible physical dose distribution. METHODS AND MATERIALS: To allow fast optimization based on dose and LET, a GPU-based Monte Carlo code was extended to provide dose-averaged LET in addition to dose for all pencil beams. After optimizing an initial IMPT plan based on physical dose, a prioritized optimization scheme is used to modify the LET distribution while constraining the physical dose objectives to values close to the initial plan. The LET optimization step is performed based on objective functions evaluated for the product of LET and physical dose (LET×D). To first approximation, LET×D represents a measure of the additional biological dose that is caused by high LET. RESULTS: The method is effective for treatments where serial critical structures with maximum dose constraints are located within or near the target. We report on 5 patients with intracranial tumors (high-grade meningiomas, base-of-skull chordomas, ependymomas) in whom the target volume overlaps with the brainstem and optic structures. In all cases, high LET×D in critical structures could be avoided while minimally compromising physical dose planning objectives. CONCLUSION: LET-based reoptimization of IMPT plans represents a pragmatic approach to bridge the gap between purely physical dose-based and relative biological effectiveness (RBE)-based planning. The method makes IMPT treatments safer by mitigating a potentially increased risk of side effects resulting from elevated RBE of proton beams near the end of range.
PURPOSE: We describe a treatment plan optimization method for intensity modulated proton therapy (IMPT) that avoids high values of linear energy transfer (LET) in critical structures located within or near the target volume while limiting degradation of the best possible physical dose distribution. METHODS AND MATERIALS: To allow fast optimization based on dose and LET, a GPU-based Monte Carlo code was extended to provide dose-averaged LET in addition to dose for all pencil beams. After optimizing an initial IMPT plan based on physical dose, a prioritized optimization scheme is used to modify the LET distribution while constraining the physical dose objectives to values close to the initial plan. The LET optimization step is performed based on objective functions evaluated for the product of LET and physical dose (LET×D). To first approximation, LET×D represents a measure of the additional biological dose that is caused by high LET. RESULTS: The method is effective for treatments where serial critical structures with maximum dose constraints are located within or near the target. We report on 5 patients with intracranial tumors (high-grade meningiomas, base-of-skull chordomas, ependymomas) in whom the target volume overlaps with the brainstem and optic structures. In all cases, high LET×D in critical structures could be avoided while minimally compromising physical dose planning objectives. CONCLUSION: LET-based reoptimization of IMPT plans represents a pragmatic approach to bridge the gap between purely physical dose-based and relative biological effectiveness (RBE)-based planning. The method makes IMPT treatments safer by mitigating a potentially increased risk of side effects resulting from elevated RBE of proton beams near the end of range.
Authors: Jan J Wilkens; James R Alaly; Konstantin Zakarian; Wade L Thorstad; Joseph O Deasy Journal: Phys Med Biol Date: 2007-02-27 Impact factor: 3.609
Authors: Drosoula Giantsoudi; Clemens Grassberger; David Craft; Andrzej Niemierko; Alexei Trofimov; Harald Paganetti Journal: Int J Radiat Oncol Biol Phys Date: 2013-06-19 Impact factor: 7.038
Authors: Drosoula Giantsoudi; Jan Schuemann; Xun Jia; Stephen Dowdell; Steve Jiang; Harald Paganetti Journal: Phys Med Biol Date: 2015-02-26 Impact factor: 3.609
Authors: Fada Guan; Lawrence Bronk; Uwe Titt; Steven H Lin; Dragan Mirkovic; Matthew D Kerr; X Ronald Zhu; Jeffrey Dinh; Mary Sobieski; Clifford Stephan; Christopher R Peeler; Reza Taleei; Radhe Mohan; David R Grosshans Journal: Sci Rep Date: 2015-05-18 Impact factor: 4.379
Authors: Radhe Mohan; Christopher R Peeler; Fada Guan; Lawrence Bronk; Wenhua Cao; David R Grosshans Journal: Acta Oncol Date: 2017-08-22 Impact factor: 4.089